BIA responds to new government investment to attract world's best in science and innovation
The BIA has to responded to the announcement from government of the inaugural UKRI Future Leaders Fellowship Scheme will receive £900 million over the next 11 years.
BIA CEO Steve Bates said: “Today’s announcement will help to boost innovation in the UK and I am delighted to see that businesses will be able to use this scheme. It is vital that the UK government continues to support young entrepreneurs and business leaders to secure the innovation pipeline in the UK for the future.”
The inaugural UKRI Future Leaders Fellowship Scheme will receive £900 million over the next 11 years, with 6 funding competitions and at least 550 fellowships awarded over the next 3 years. The investment will provide up to 7 years of funding for early-career researchers and innovators, including support for part-time awards and career-breaks, providing flexibility to researchers to tackle ambitious and challenging areas. For the first time ever, this type of scheme will now be open to businesses as well as universities. The scheme aims to help the next generation of tech entrepreneurs, business leaders and innovators get the support they need to develop their careers. It is open to best researchers from around the world, ensuring the UK continues to attract the most exceptional talent wherever they may come from.
Complementing the Future Leaders Fellowship Scheme, the Royal Society, Royal Academy of Engineering, British Academy, and Academy of Medical Sciences will collectively receive £350 million for the prestigious fellowships schemes. This funding will enhance the research talent pipeline and increase the number of fellowships on offer for high skilled researchers and innovators.
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.
Ed Sexton, Communications and Media Relations Manager, BIA email@example.com 0207 630 2196